India’s Modi is on a landmark visit to the U.S. Here’s what to expect
Indian Prime Minister Narendra Modi is set to meet U.S. president Joe Biden on Thursday, and analysts say talks on defense and technology are on the agenda.
Tesla secret configuration allows select drivers to use Autopilot, FSD without a nag to take the wheel
The researcher has nicknamed the feature “Elon Mode,” but this is not the company’s internal nomenclature for it, he said.
Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
Danish drugmaker Novo Nordisk initiated federal court lawsuits against medical spas and wellness clinics in New York, Texas, Florida and Tennessee.
Amazon faces Senate probe over warehouse safety
Sen. Bernie Sanders, who chairs the HELP committee, wrote a letter to Amazon CEO Andy Jassy on Tuesday regarding the company’s warehouse safety record.
Average credit card interest rate is a record 20.69%, but 0% offers are still available, experts say
The Federal Reserve’s pause on interest rate hikes will do little to help borrowers struggling with expensive credit card debt.
Biden to meet with A.I. experts in San Francisco
Biden is expected to meet with Center for Humane Technology leader Tristan Harris, Common Sense CEO Jim Steyer, and Khan Academy Founder and CEO Sal Khan.
Gannett sues Google over its alleged ad tech monopoly
It adds to an already-extensive list of lawsuits against the company for alleged anti-competitive behavior.
Hunter Biden to plead guilty to federal tax crimes, take deal on gun charge
Hunter Biden, the son of President Joe Biden, has been under investigation for tax and gun offenses by a Delaware federal prosecutor appointed by Donald Trump.
Amazon HQ2 is not matching the original hype. The economy is partly to blame
Amazon’s scaled back Amazon HQ2 plans show an economy, from inflation to interest rates and a tight labor market, that is slowing corporate expansion ambitions.
Eli Lilly to acquire Dice Therapeutics for $2.4 billion in autoimmune treatment push
Dice is a biopharmaceutical company that uses a proprietary technology platform to develop new oral therapeutic drugs for autoimmune diseases.
